{"schema_version":"secwatch.filing_event.v1","accession":"0001759655-22-000083","form_type":"8-K","ticker":"PRVA","cik":"0001759655","company_name":"Privia Health Group, Inc.","filed_at":"2022-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.940007+00:00","generated_at":"2026-06-24T21:45:14.853653+00:00","sec_items":["7.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Privia Health reaffirms FY2022 adjusted EBITDA guidance of $52M-$56M","bullets":["Reiterates full-year 2022 adjusted EBITDA range of $52M-$56M, representing 25.6%-35.3% growth over prior year.","Expects approximately 90% of adjusted EBITDA to convert to free cash flow.","No reconciliation provided for non-GAAP forward-looking measures; GAAP equivalents not forecastable without unreasonable effort.","Guidance subject to risks outlined in annual report and other SEC filings."],"urls":{"canonical":"https://secwatch.observer/filing/0001759655-22-000083","json":"https://secwatch.observer/filing/0001759655-22-000083.json","markdown":"https://secwatch.observer/filing/0001759655-22-000083.md","text":"https://secwatch.observer/filing/0001759655-22-000083.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1759655/000175965522000083/0001759655-22-000083-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1759655/000175965522000083/prva-20220701.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T21:45:14.853653+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}